Companies: 10,795·Total market cap: $144.5T
NKGen Biotech, Inc. Common Stock

NKGen Biotech, Inc. Common Stock

NKGNOTCHealthcare● Active
$0.06
+$0.00(+0.00%)
Market Cap$7836133
P/E Ratio
52W High$0.765
52W Low$0.001
Overview

NKGen Biotech, Inc. Common Stock(NKGN)股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · NKGN · 截至 Jun 9, 2026

关键指标

EPS (TTM)$-0.96nkgn eps ttm · nkgn earnings per shareEarnings history
PE Ratio (TTM)nkgn pe ratio ttm · nkgn price to earningsPE Ratio deep dive
Revenue (TTM)652000.00nkgn revenue ttm · nkgn annual revenueFull revenue history
Dividend Yield不分红does nkgn pay dividends · nkgn dividend yieldDividend history
Shares Outstanding28.8Mnkgn shares outstanding · nkgn floatShares outstanding history
Next EarningsTBAnkgn earnings date · nkgn next earningsEarnings history

财务快照

完整财报
FY 2024Revenue$0.00
202220232024
nkgen biotech, inc. common stock revenue · nkgn revenue 2024
FY 2024Net Income-$44.3M▲ +46.61% YoY
202220232024
nkgen biotech, inc. common stock net income · nkgn profit 2024
FY 2024EPS$-1.54▲ +71.38% YoY
202220232024
nkgn eps · nkgen biotech, inc. common stock earnings per share 2024
TTM:Revenue: $652000.00Net Income: -$23.6MEPS: $-0.96View income statement →

股票表现

完整历史
1D+0.00%
1W+0.00%
1M-25.00%
3M-70.00%
YTD+20.00%
1Y-82.35%
5Y-98.95%

关于 NKGen Biotech, Inc. Common Stock

CEOPaul Y. Song
IPO DateOct 2, 2023
Employees63
CountryUS

NKGen Biotech, Inc. Common Stock NKGen Biotech, Inc., a biotechnology company in the clinical trial phase, was established in 2017 and has its headquarters in Santa Ana, California. This company is dedicated to creating and marketing…

what is nkgen biotech, inc. common stock · nkgn stock overview · nkgen biotech, inc. common stock company profile · who is nkgen biotech, inc. common stock ceo · nkgn OTC · nkgen biotech, inc. common stock headquarters · nkgen biotech, inc. common stock business segments

关于股票概览与关键数据

NKGen Biotech, Inc. Common Stock(NKGN)是 Biotechnology 行业的 Healthcare 类公司,于 Oct 2, 2023 在 OTC 上市。截至最近交易日,NKGN 股价为 $0.06,市值约为 $7.8M。过去12个月累计回报 -82.35%,年初至今回报 +20.00%。

2024 财年 NKGen Biotech, Inc. Common Stock 营收 —。完整财务数据(营收历史、盈利、资产负债表)请使用上方标签页。

常见问题

截至最近一个交易日,NKGen Biotech, Inc. Common Stock(NKGN)股价为 $0.06,在 OTC 上市,52周区间为 $0.00 – $0.77。

NKGN 最新股价NKGN quote todaylive ticker 实时行情
数据来源:Financial Modeling Prep最后更新:Jun 9, 2026本内容不构成投资建议